TCTAP A-144 Effect of Anti–Proliferative Drug Concentration on Short Term Outcomes in Patients Undergoing Second Generation Drug Eluting Stent Implantation

TCTAP A-144 Effect of Anti–Proliferative Drug Concentration on Short Term Outcomes in Patients Undergoing Second Generation Drug Eluting Stent Implantation

Conclusion At 30 days, in patients of acute coronary syndromes, the newer second generation DES (XIENCE PRO) despite having lower anti-proliferative drug concentration is non inferior to XIENCE PRIME stent in safety outcomes.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2016-04, Vol.67 (16), p.S64-S64
Hauptverfasser: Ghose, Tapan, Yadav, Supratiksh, Arora, Kuldeep, Kukreti, Bharat, Pathak, Satya Nand
Format: Artikel
Sprache:eng
Schlagworte:
Acute coronary syndromes
Angina pectoris
Cardiology
Cardiovascular
Heart attacks
Internal Medicine
Thrombosis
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Conclusion At 30 days, in patients of acute coronary syndromes, the newer second generation DES (XIENCE PRO) despite having lower anti-proliferative drug concentration is non inferior to XIENCE PRIME stent in safety outcomes.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2016.03.176